Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hanneke Schuitemaker and Georgi Shukarev.
Hanneke Schuitemaker
Connection Strength
0.346
Georgi Shukarev
  1. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 05 13; 384(19):1824-1835.
    View in: PubMed
    Score: 0.231
  2. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021 06 10; 384(23):2187-2201.
    View in: PubMed
    Score: 0.059
  3. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 2021 05 21; 39(22):3081-3101.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.